Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/31995| Title: | Commentary on Bamat et al | Authors: | Saad, Everardo D. BUYSE, Marc |
Issue Date: | 2020 | Publisher: | SAGE PUBLICATIONS LTD | Source: | CLINICAL TRIALS, 17(5), p. 560-561, (Art N° 1740774520941442) | Notes: | Saad, ED (corresponding author), Int Inst Drug Dev, Ave Prov 3, Louvain La Neuve, Belgium. everardo.saad@iddi.com |
Other: | Saad, ED (corresponding author), Int Inst Drug Dev, Ave Prov 3, Louvain La Neuve, Belgium. everardo.saad@iddi.com | Document URI: | http://hdl.handle.net/1942/31995 | ISSN: | 1740-7745 | e-ISSN: | 1740-7753 | DOI: | 10.1177/1740774520941442 | ISI #: | WOS:000548898600001 | Rights: | 2020 by The Society for Clinical Trials | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| saad-buyse-2020-commentary-on-bamat-et-al.pdf Restricted Access | Published version | 90.66 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.